ATE325114T1 - Acylhydrazinderivate, verfahren zu ihrer herstellung und ihre verwendung - Google Patents

Acylhydrazinderivate, verfahren zu ihrer herstellung und ihre verwendung

Info

Publication number
ATE325114T1
ATE325114T1 AT00940768T AT00940768T ATE325114T1 AT E325114 T1 ATE325114 T1 AT E325114T1 AT 00940768 T AT00940768 T AT 00940768T AT 00940768 T AT00940768 T AT 00940768T AT E325114 T1 ATE325114 T1 AT E325114T1
Authority
AT
Austria
Prior art keywords
optionally substituted
group
hydrogen
hydrocarbon group
hydrocarbyl
Prior art date
Application number
AT00940768T
Other languages
English (en)
Inventor
Fumio Itoh
Hiroshi Hosono
Masaki Kawamura
Keiji Kubo
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Application granted granted Critical
Publication of ATE325114T1 publication Critical patent/ATE325114T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Vascular Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT00940768T 1999-06-22 2000-06-21 Acylhydrazinderivate, verfahren zu ihrer herstellung und ihre verwendung ATE325114T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP17605799 1999-06-22
JP26628099 1999-09-20
JP2000017956 2000-01-24

Publications (1)

Publication Number Publication Date
ATE325114T1 true ATE325114T1 (de) 2006-06-15

Family

ID=27324198

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00940768T ATE325114T1 (de) 1999-06-22 2000-06-21 Acylhydrazinderivate, verfahren zu ihrer herstellung und ihre verwendung

Country Status (7)

Country Link
US (1) US6723722B1 (de)
EP (1) EP1188755B1 (de)
AT (1) ATE325114T1 (de)
AU (1) AU5566300A (de)
CA (1) CA2383492A1 (de)
DE (1) DE60027718T2 (de)
WO (1) WO2000078747A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1302462A4 (de) * 2000-07-17 2007-07-18 Takeda Pharmaceutical Sulfonderivate, verfahren zu ihrer herstellung und ihre verwendung
US7109200B2 (en) * 2000-11-08 2006-09-19 Takeda Pharmaceutical Company Limited Carbamate derivatives, process for producing the same and use thereof
WO2003078389A1 (en) * 2002-03-15 2003-09-25 Kissei Pharmaceutical Co., Ltd. Novel crystals of 5-hydroxycarbamimidoyl-2-hydroxybenzenesulfonamide derivative
AU2003228825A1 (en) 2002-05-03 2003-11-17 Elan Pharmaceuticals, Inc. Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists
WO2004035579A1 (ja) * 2002-10-15 2004-04-29 Takeda Pharmaceutical Company Limited イミダゾピリジン誘導体、その製造法および用途
US20070004736A1 (en) * 2002-11-22 2007-01-04 Keiji Kubo Imidazole derivative, process for producing the same, and use
CN100513398C (zh) 2002-12-03 2009-07-15 Axys药物公司 作为因子viia抑制剂的2-(2-羟基联苯-3-基)-1h-苯并咪唑-5-甲脒衍生物
ES2897422T3 (es) 2004-05-14 2022-03-01 Vertex Pharma Compuestos pirroles como inhibidores de proteínas cinasas ERK y composiciones farmacéuticas que contienen esos compuestos
TWI396686B (zh) 2004-05-21 2013-05-21 Takeda Pharmaceutical 環狀醯胺衍生物、以及其製品和用法
RU2318818C1 (ru) * 2006-04-12 2008-03-10 Общество С Ограниченной Ответственностью "Исследовательский Институт Химического Разнообразия" Азагетероциклы, комбинаторная библиотека, фокусированная библиотека, фармацевтическая композиция и способ получения (варианты)

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3124610A (en) * 1964-03-10 Preparation of intermediates
US3067237A (en) * 1959-04-14 1962-12-04 Sterling Drug Inc Lower-alkyl mono-or bis-(alkanesulfonamido) benzoate esters
GB992961A (en) * 1960-07-28 1965-05-26 Ciba Ltd Process for the manufacture of amino acid derivatives
US3441570A (en) * 1966-01-20 1969-04-29 Parke Davis & Co 3-tertiary aminoalkylamino-3-phenyl oxindole compounds
JPS5216156B2 (de) * 1972-08-16 1977-05-07
DE2602422A1 (de) * 1976-01-23 1977-07-28 Thomae Gmbh Dr K Neue 6-aminopenicillansaeuren, ihre salze und derivate und verfahren zu ihrer herstellung und diese enthaltende arzneimittel
AU561156B2 (en) * 1983-02-18 1987-04-30 Wellcome Foundation Limited, The Hydantoin derivatives
JPH07119982B2 (ja) * 1986-04-18 1995-12-20 富士写真フイルム株式会社 ハロゲン化銀写真感光材料
GB8704158D0 (en) * 1987-02-23 1987-04-01 Wellcome Found Substituted hydantoin compounds
JPH0782221B2 (ja) * 1988-06-28 1995-09-06 富士写真フイルム株式会社 ハロゲン化銀写真感光材料
GB9011589D0 (en) * 1990-05-24 1990-07-11 Wellcome Found Amino bicyclic compounds
US5182272A (en) * 1991-05-03 1993-01-26 G. D. Searle & Co. 8-substituted-dibenz[b,f][1,4]oxazepine-10(11)-carboxylic acid, substituted hydrazides, pharmaceutical compositions, and methods for treating pain
DE4206858A1 (de) * 1992-03-05 1993-09-09 Behringwerke Ag Glycopeptid-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische mittel
DE4228717A1 (de) 1992-08-28 1994-03-03 Cassella Ag Imidazolidin-Derivate
TW394760B (en) 1993-09-07 2000-06-21 Hoffmann La Roche Novel Carboxamides, process for their preparation and pharmaceutical composition containing the same
IL115420A0 (en) 1994-09-26 1995-12-31 Zeneca Ltd Aminoheterocyclic derivatives
US5612353A (en) 1995-06-07 1997-03-18 Rhone-Poulenc Rorer Pharmaceuticals Inc. Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds
JPH10161270A (ja) * 1996-10-01 1998-06-19 Fuji Photo Film Co Ltd 熱現像記録材料
UA56197C2 (uk) 1996-11-08 2003-05-15 Зенека Лімітед Гетероциклічні похідні
AR012374A1 (es) * 1997-04-15 2000-10-18 Smithkline Beecham Corp Inhibidores de proteasas, composiones farmaceuticas y usos para la preparacion de medicamentos.
US6359134B1 (en) 1997-05-30 2002-03-19 Takeda Chemical Industries, Ltd. Sulfonamide derivatives, their production and use
JP3830060B2 (ja) * 1997-06-09 2006-10-04 富士写真フイルム株式会社 熱現像記録材料
DE19728524A1 (de) * 1997-07-04 1999-01-07 Merck Patent Gmbh Cyclische Azapeptide
GB9715892D0 (en) 1997-07-29 1997-10-01 Zeneca Ltd Heterocyclic compounds
JPH11119373A (ja) * 1997-10-14 1999-04-30 Fuji Photo Film Co Ltd 熱現像記録材料
JPH11133545A (ja) * 1997-10-31 1999-05-21 Fuji Photo Film Co Ltd 熱現像記録材料
AU1692399A (en) 1997-12-26 1999-07-19 Mochida Pharmaceutical Co., Ltd. Aromatic compounds having cyclic amino or salts thereof
YU47600A (sh) 1998-01-27 2002-09-19 Aventis Pharmaceuticals Products Inc. SUPSTITUISANI OKSOAZAHETEROCIKLIL INHIBITORI FAKTORA Xa
CN1290254A (zh) 1998-02-05 2001-04-04 武田药品工业株式会社 氨磺酰衍生物及其制备和用途
JPH11327077A (ja) * 1998-05-11 1999-11-26 Fuji Photo Film Co Ltd 熱現像記録材料
US6239151B1 (en) * 1998-06-26 2001-05-29 Hoffmann-La Roche Inc. Compounds as inhibitor of tumor necrosis factor alpha release

Also Published As

Publication number Publication date
DE60027718D1 (de) 2006-06-08
AU5566300A (en) 2001-01-09
CA2383492A1 (en) 2000-12-28
EP1188755B1 (de) 2006-05-03
US6723722B1 (en) 2004-04-20
WO2000078747A8 (en) 2001-03-29
DE60027718T2 (de) 2007-05-16
WO2000078747A1 (en) 2000-12-28
EP1188755A4 (de) 2003-01-08
EP1188755A1 (de) 2002-03-20

Similar Documents

Publication Publication Date Title
EP1180518A4 (de) 5-pyridyl-1,3-azol-derivate, verfahren zu ihrer herstellung und ihre verwendung
DE60315265D1 (de) Stickstoffhaltige heterocyclische verbindung und arzneimittel davon
EP1695961A4 (de) Harnstoffderivative, verfahren zu deren herstellung und verwendung
FI953968A0 (fi) Antraniiliset happojohdannaiset
WO2000047580A3 (en) Phenyl urea and phenyl thiourea derivatives
CA2325741A1 (en) Urea derivatives having tnf- .alpha. production inhibitory effects
PT1178967E (pt) Derivados de quinolina como inibidores de enzimas mek
DE69120581D1 (de) 1,8-Naphthyridin-2-on-Derivate
ATE302778T1 (de) N-substituierte 4-aminopteridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
NO942372L (no) Propensyrederivater
DE69929669D1 (de) Zyklische Amidderivate die Cathepsin K hemmen
DE60140748D1 (de) Thiazol-derivate zur verwendung als entzündungshemmende mittel
DE60027718D1 (de) Acylhydrazinderivate, verfahren zu ihrer herstellung und ihre verwendung
ATE183739T1 (de) N-acylpyrrolidine, verfahren zur herstellung und ihre verwendung zur prevention und/oder behandlung von amnesie
HUP0002425A1 (hu) 2-(Iminometil) amino-fenil-származékok, eljárás ezek előállítására, alkalmazásuk gyógyszerként és ilyen vegyületeket tartalmazó gyógyászati készítmények
ATE86991T1 (de) Analgetische carbonsaeureamid-derivate.
ATE13178T1 (de) 2-oxoazetidin-derivate, ihre herstellung und verwendung.
ATE421524T1 (de) 5-ring-heterocyclen, ihre herstellung, ihre verwendung als inhibitoren der leukozytenadhäsion und sie enthaltende pharmazeutische präparate
ATE146479T1 (de) Modifizierte oligodeoxyribonukleotide, ihre herstellung und ihre therapeutische verwendung
ATE168376T1 (de) Triazolopyridazin-derivate, ihre herstellung und verwendung
DK0417790T3 (da) S-triazolo(3,4-i)purin-derivater
DE60027908D1 (de) Harnstoff-verbindungen, ein verfahren zu deren herstellung und ihre verwendung
DE60014936D1 (de) Trizyklische dihydrobenzofurane, verfahren zu deren herstellung und mittel
ATE205209T1 (de) Chinolincarbonsäurederivate und ihre salze
ES2159693T3 (es) Ligandos 5ht1dalfa y 5ht2a.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties